February 22, 2018
Rose
Palo Alto, California-based Cognoa’s machine learning app for pediatric behavioral health has received categorization from the FDA as a Class 2 diagnostic medical device for autism, according to an announcement from the company.
from MobiHealthNews http://ift.tt/2HBimlN
February 22, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Nokia creates plan for digital health, announces it could cut 425 jobs- 3D heart model maker HeartFlow lands $240M in funding
- FareWell changes name to Better Therapeutics, sees 0.8 percent A1c reduction in small study
- Digital health news briefs for 2/15/2018
- FDA budget requests include clinical software, natural language processing, real-time device data
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment